Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding Gross Margin

The Gross Margin of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Nov 2, 2026 is 92.77 %. In the previous year, Gross Margin was 94.22 % — a change of -1.54% (lower).

Gross Margin

92.77 %

YoY

-1.54%

Last updated:

Gross Margin of Tibet Rhodiola Pharmaceutical Holding is 2025 92.77 % . Gross Margin of Tibet Rhodiola Pharmaceutical Holding was 2024 94.22 % . It decreases by -1.54% lower compared to the previous year.

Tibet Rhodiola Pharmaceutical Holding's gross margin stands at 92.8%, up from 89.4% several years earlier.

The Tibet Rhodiola Pharmaceutical Holding Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
79.90 CNY
Jan 1, 2019
83.45 CNY
Jan 1, 2020
85.75 CNY
Jan 1, 2021
89.44 CNY
Jan 1, 2022
91.99 CNY
Jan 1, 2023
94.94 CNY
Jan 1, 2024
94.22 CNY
Jan 1, 2025
92.77 CNY
The Tibet Rhodiola Pharmaceutical Holding Gross Margin history
YEARGross MarginYoY
92.77 %-1.54%
94.22 %-0.75%
94.94 %+3.21%
91.99 %+2.84%
89.44 %+4.31%
85.75 %+2.75%
83.45 %+4.44%
79.90 %+8.34%
73.75 %-3.36%
76.31 %+136.27%
32.30 %+59.62%
20.24 %+10,104.77%
0.20 %+0.65%
0.20 %+9.65%
0.18 %+4.00%
0.17 %+1.70%
0.17 %+12.58%
0.15 %+22.98%
0.12 %-52.51%
0.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co. generates revenue through the manufacture and wholesale of pharmaceutical products. The company distributes proprietary drug products and processes pharmaceuticals, serving markets across South China, North China, East China, Central China, and overseas regions. Its primary customers are pharmaceutical distributors and healthcare providers within these regions, focusing on the distribution of its proprietary drug portfolio. The firm's revenue streams are derived from the wholesale of manufactured pharmaceuticals and the processing of pharmaceutical products. It operates through a network of distributors in key Chinese regions and overseas markets, targeting healthcare institutions and pharmacies that require its proprietary drug solutions. The company's business model emphasizes regional distribution networks to reach its target segments efficiently. Tibet Rhodiola Pharmaceutical Holding Co. relies on its proprietary drug products for sales, with a strong presence in multiple Chinese regions and overseas markets. The company's revenue is driven by the distribution of these products through its established wholesale channels, catering to the healthcare sector's demand for pharmaceutical solutions in its operational areas. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

Gross Margin of Tibet Rhodiola Pharmaceutical Holding is 92.77 % in 2025.

Gross Margin of Tibet Rhodiola Pharmaceutical Holding changed from 94.22 % to 92.77 %, representing a -1.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Tibet Rhodiola Pharmaceutical Holding with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Tibet Rhodiola Pharmaceutical Holding

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding